Please login to the form below

Not currently logged in
Email:
Password:

social care

This page shows the latest social care news and features for those working in and with pharma, biotech and healthcare.

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

We are grateful for the support of the UK Government, including from its Department of Health and Social Care and National Institute for Health Research, to advance this important research,” he

Latest news

More from news
Approximately 13 fully matching, plus 237 partially matching documents found.

Latest Intelligence

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    found that patients who had received an influenza vaccine were 8% less likely to need intensive care treatment and 17% less likely to die. ... It will also be offered to household contacts of people on the NHS Shielded Patient List and all health and all

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    The challenge in achieving this is that current standard of care for cancer patients tends to overlook patient mindset interventions. ... As the community strives to target cancer with the latest innovative treatments, we should simultaneously strive to

  • Recruiting for a COVID-19 clinical trial? Recruiting for a COVID-19 clinical trial?

    By Kristian Webb. Recently, the UK’s Secretary of State for Health and Social Care, Matt Hancock, appealed for more volunteers for COVID-19 clinical trials.He explained that “the bigger ... 4. Talk about the bigger picture. The pandemic has given

  • Great expectations: the urgent need for common purpose in Alzheimer’s disease Great expectations: the urgent need for common purpose in Alzheimer’s disease

    Effective AD treatments will be a cost to health systems but in return will bring relatively little cost benefit to those health systems – by reducing or delaying the level of care ... people need, they will offer most benefit to social care systems

  • The roaring ‘20s and Generation Z The roaring ‘20s and Generation Z

    This year alone, there will be five pertinent pieces of legislation including Bills on NHS Funding and the Long Term Plan, Mental Health, Social Care, Patient Safety and Medicines and Medical ... With Matt Hancock being retained as Secretary of State for

More from intelligence
Approximately 0 fully matching, plus 42 partially matching documents found.

Latest appointments

  • NICE looks internally for new chief executive NICE looks internally for new chief executive

    The National Institute for Health and Care Excellence (NICE) has appointed Gillian Leng (pictured above), CBE, as its new chief executive, who assumes the role from long-serving chief Sir Andrew ... Leng has been deputy chief executive at NICE since 2007

  • greyhealth group appoints digital strategy director greyhealth group appoints digital strategy director

    Previously, he was digital team lead for Care UK, a health and social care service organisation, and also brings experience from the UK's Medicines and Healthcare products Regulatory Agency.

  • GK Strategy appoints head of health and social care GK Strategy appoints head of health and social care

    Andrew Nye joins the public affairs consultancy. Public affairs consultancy GK Strategy has appointed Andrew Nye to the newly-created position of head of health and social care. ... He will head up a new health and social care practice at GK, servicing a

  • Jenny Ousbey moves from Lexington to Westminster Advisers Jenny Ousbey moves from Lexington to Westminster Advisers

    She has also served as a senior political advisor and parliamentary researcher for former care services minister Paul Burstow, advising on a range of health and social care issues between 2011

  • Portland Health appoints Jamie Hewitt as an account director Portland Health appoints Jamie Hewitt as an account director

    During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to increase access to medicines, raise disease awareness and influence legislation on health, social care and welfare reform.

More from appointments
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest from PMHub

  • Healthcare in a lockdown

    25.7% of patients said they didn’t need any medical care during the lockdown. ... Even so, for those who received enough care, was it the right kind of care?

  • Love in the Time of Coronavirus

    History shows that epidemics are often followed by social upheavals, and good things sometimes come out of tragedy. ... 1. First and foremost, lasting gratitude to the healthcare and social care workers who put themselves at risk to help others.

  • Digital Therapeutics Landscape in Europe Digital Therapeutics Landscape in Europe

    The need for continued medical care combined with social distancing has led to a spike in use of digital health tools worldwide. ... https://www.cnbc.com/2020/03/26/investments-in-digital-health-care-could-accelerate-after-coronavirus-credit-suisse-says.h

  • Using Health IT to Improve the Healthcare System

    They also explored how NZHIT and its members are working collaboratively across the health sector to position digital health technologies as a key enabler of quality health and social care services.

  • Can social listening can improve patient recruitment and retention? Can social listening can improve patient recruitment and retention?

    How social listening can enhance clinical trial design. Get direct access to lifestyle, behaviour &barrier insights. ... For example, if through social media listening you understand that your target population are parents with young children to care for,

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics